Shares of Evotec SE (ETR:EVT - Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of €7.59 ($8.25) and traded as low as €7.10 ($7.72). Evotec shares last traded at €7.12 ($7.73), with a volume of 2,952,098 shares traded.
Evotec Trading Down 2.0 %
The company has a 50-day moving average price of €8.29 and a two-hundred day moving average price of €7.61. The stock has a market capitalization of $1.22 billion, a P/E ratio of -7.13, a price-to-earnings-growth ratio of 0.98 and a beta of 1.05.
Evotec Company Profile
(
Get Free Report)
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.
Recommended Stories
Before you consider Evotec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evotec wasn't on the list.
While Evotec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
